ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 26 of 49
Up
JMBS 2018, 3(1): 139–143
https://doi.org/10.26693/jmbs03.01.139
Clinical Medicine

Effect of Smoking on the Functional State of the Respiratory System in Patients with Psoriasis

Kovalova O. S., Fedotov V. P.
Abstract

The article deals with studying the effect of smoking on the functional state of the respiratory system with spirography, the degree of saturation of arterial blood with oxygen (the level of oxygenation) in patients with psoriasis. Materials and methods: 65 patients with psoriasis aged 25-56 (40 men, and 25 women) were examined. 23 of them did not smoke, and 42 smoked 8 years or more. We studied patients’ spirography and measured oxygenation level the frequency of respiratory movements (BHD). Results and discussion: According to spirography, tobacco smokers had bronchial obstruction, and obstructive airway changes, according to the vital capacity of the lungs and respiratory metabolism, as well as low values of forced expiratory volume in the first second and the Tiffno index in contrast to patients who did not smoke. After physical exertion, the level of oxygenation of blood in patients who smoked was statistically reliably reduced, which indicates a violation of gas exchange in these patients. The established high values of the frequency of respiratory movements after physical exertion in patients with psoriasis of tobacco smokers indicated a violation of pulmonary ventilation. Conclusions: The adverse effect of smoking on psoriasis is established as a result of changes in higher respiration, oxygen saturation of the blood, which requires a certain therapeutic correction.

Keywords: Psoriasis, smoking, breathing, blood, oxygen, lungs, sex, function

Full text: PDF (Ukr) 201K

References
  1. Belov AA, Lakshina NA. Otsenka funktsii vneshnego dykhaniya: metodicheskie podkhody i diagnosticheskoe znachenie. M: Russkiy vrach, 2006. 68 s. [Russian]
  2. German AK. Sostoyanie legochnykh obemov, emkostey i alveolyarnoy ventilyatsii u kurilshchikov. Vrachebnoe delo. 1990; 3: 37-8. [Russian]
  3. Kadaner YeI. Kompleksna terapiya khvorykh na ekzemu kurtsiv tyutyunu: avtoref. dis. … kand. med. nauk, Abstr. PhDr. (Med.). Kharkiv, 2012. 16 s. [Ukrainian]
  4. Psoriaz: adaptovana klinichna nastanova, zasnovana na dokazakh. Kod MKKh-10: L40 – Psoriaz. Robocha versiya № 4 prefinal. K, 2013. 218 s. [Ukrainian]
  5. Syzon OO, Stepanenko VI. Kontrol za rozvytkom ta perebihom suputnoi patolohiyi u khvorykh na artropatychnyi psoriaz. Ukr zhurnal dermatolohiyi, venerolohiyi, kosmetolohiyi. 2014; 2 (53): 13-23. [Ukrainian]
  6. Nakaz MOZ Ukrainy № 917 vid 03.12.2009. Systemy dlya provedennya klinichnykh, khimichnykh ta imunolohichnykh analiziv. Immulite: dodatok Immulitenicotine-metabolite do reyestratsiynoho svidotstva vyrobu № 9128/2009 vid 03.12.2009. Systemy dlya provedennya klinichnykh, khimichnykh ta imunolohichnykh analiziv. Immulite. [Ukrainian]
  7. Tverdokhlib IV, Pertseva NO, Turlyun TS. Dynamika morfolohichnykh zmin hranul trombotsytiv u khvorykh na arterialnu hipertenziyu z vysokym kardiovaskulyarnym ryzykom pry zastosuvanni lazortanu kaliyu. Morphologia. 2014; 8 (2): 61-6. [Ukrainian]
  8. Chebotar AI. Osoblyvosti perebihu psoriazu na Kirovohradshchyni. Ukr zhurnal dermatolohiyi, venerolohiyi, kosmetolohiyi. 2011; 1 (40): 40-3. [Ukrainian]
  9. Balfour DJ, Ridley DL. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction? Farmacol Biochem Behav. 2000 May; 66 (1): 70-85. https://www.ncbi.nlm.nih.gov/pubmed/10837846. https://doi.org/10.1016/S0091-3057(00)00205-7
  10. Balfour DJ. The pharmacology underlying pharmacotherapy for tobacco dependence: a focus on bupropion. Int J Clin Pract. 2001; 55: 53-7. https://www.ncbi.nlm.nih.gov/pubmed/11219320
  11. Choi HY, Park HC, Ha SK. Salt Sensitivity and Hypertension: A Paradigm Shift from Kidney Malfunction to Vascular Endothelial Dysfunction. Electrolyte Blood Press. 2015; 13 (1): 7-16. https://www.ncbi.nlm.nih.gov/pubmed/26240595. https://www.ncbi.nlm.nih.gov/pmc/articles/4520886. https://doi.org/10.5049/EBP.2015.13.1.7
  12. Garsia-Rodriguez S, Arias-Santiago S, Perandrés-López R, Castellote L, Zumaquero E, Navarro P, Buendía-Eisman A, Ruiz JC, Orgaz-Molina J, Sancho J, Zubiaur M. Increased gene expression of Tollike receptor 4 on peripheral blood momonuclear cells in patients with psoriasis. JEADV. 2013; 27 (5): 242-50. https://www.ncbi.nlm.nih.gov/pubmed/23457721. https://doi.org/10.1111/j.1468-3083.2011.04372.x
  13. Harden JL, Krueger JG, Bowcock AM. The immunogenetics of psoriasis a comprehensive. J Autoimmun. 2015; 64: 66-73. https://www.ncbi.nlm.nih.gov/pubmed/26215033. https://www.ncbi.nlm.nih.gov/pmc/articles/4628849. https://doi.org/10.1016/j.jaut.2015.07.008
  14. Mantovani A, Gisondi Р, Lonardo А, Targher G. Relation-ship between Non-Alcoholic Fatty Liver Diswase and Psoriasis A Novel Hepato-Dermal Axis. Int J Mol Sci. 2016; 17 (2): 217. https://doi.org/10.3390/ijms17020217
  15. Mrowietz U, Kragballe К, Reich К, Spuls P, Griffiths CEM, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, et al. Definition of theatment goais for moberate to severe psoriasis: a European consensus. Arch Dermatol Res. 2011 Jan; 303 (1): 1-10. https://www.ncbi.nlm.nih.gov/pmc/articles/3016217. https://doi.org/10.1007/s00403-010-1080-1
  16. Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. JEADV. 2012 Mar; 26 Suppl 2: 3-11. https://www.ncbi.nlm.nih.gov/pubmed/22356630. https://doi.org/10.1111/j.1468-3083.2011.04410.x
  17. World Health Organization. International statistical classification of diseases and related health problems (ICD 10). Tenth revision. Geneva [digital resource]: WHO. 1992. [Cited 2017, 28 Nov]. Available from: http//www.who.int/occupational health/publications/en/oehi CD10.pdf.